Rexulti 0.5 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FQHZN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,422
Award facts
- Contract value 100% obligated
- $15,422.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $15,422.40 to AmerisourceBergen Drug Corp for 30 tablets of Rexulti 0.5 mg on August 18, 2025, with completion targeted for August 19, 2025. This competitively awarded, firm fixed-price contract requires delivery to AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This comprehensive pharmaceutical prime vendor contract enables AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs globally.
Rexulti is an antipsychotic medication used in the treatment of psychiatric conditions including schizophrenia and bipolar disorder. AmerisourceBergen, as a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated substantial capacity to fulfill federal medical procurement needs through its extensive portfolio of competitively awarded contracts with DLA covering diverse therapeutic domains. The contract received no set-aside designation, reflecting the vendor's capability to compete openly for federal medical supply requirements. This delivery order exemplifies the operational execution of the larger IDC vehicle, which serves critical healthcare needs across the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FQHZN?
SPE2DB25FQHZN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 18, 2025.
How much is contract SPE2DB25FQHZN worth?
The government has obligated $15,422 on SPE2DB25FQHZN.
Is contract SPE2DB25FQHZN an order under another contract?
Yes. SPE2DB25FQHZN is a delivery order under SPE2DB25D3005, an indefinite delivery contract.
Was contract SPE2DB25FQHZN competed?
The extent of competition for SPE2DB25FQHZN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award